Equifax reported $6.44B of revenue over the trailing twelve months, +10% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $6.44B (to Q2 2026). Net income: $691M, trailing twelve months to Q2 2026. Free cash flow: $1.10B, trailing twelve months to Q2 2026. Operating margin: 18%, trailing twelve months to Q2 2026.

EFXEquifax

Industrials

$145.75-44% 1Y

$145.75

$137.2452 weeks$255.41

EFX as reported

Equifax reported $6.44B of revenue over the trailing twelve months, +10% on the year before. 11 reported series are charted on this page, each one as filed.

$6.44B

Revenue, trailing twelve months · to Q2 2026 · +10% against the twelve months before

Net income: $691M
Net income · +8.1% year on year · trailing twelve months to Q2 2026
Free cash flow: $1.10B
Free cash flow · +21% year on year · trailing twelve months to Q2 2026
Operating margin: 18%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for EFX, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$6.44B	+10%	Q2 2026
Net income	$691M	+8.1%	Q2 2026
EPS	$5.68	+11%	Q2 2026
Gross margin	56%	n/a	Q2 2026
Operating margin	18%	n/a	Q2 2026
Net margin	11%	n/a	Q2 2026
ROE	15%	n/a	Q2 2026
ROA	5.7%	n/a	Q2 2026
ROIC	9.2%	n/a	Q2 2026
Free cash flow	$1.10B	+21%	Q2 2026
P/E	25.7	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.